 | • レポートコード：GIR-2104Z02678 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥494,160 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥741,240 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥988,320 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、がん治療・支持療法薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。がん治療・支持療法薬の種類別市場規模（がん治療薬、支持療法薬）、用途別市場規模（病院、小売薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・がん治療・支持療法薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Abbott Laboratories、AstraZeneca plc、Astellas Pharma、Bristol-Myers Squibb、Johnson & Johnson、Eli Lilly、Novartis、Pfizer、Sanofi、Teva Pharmaceuticals、Takeda Pharmaceuticals、AbbVie ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：がん治療薬、支持療法薬 ・用途別分析2016年-2026年：病院、小売薬局 ・がん治療・支持療法薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・がん治療・支持療法薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・がん治療・支持療法薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・がん治療・支持療法薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・がん治療・支持療法薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Cancer Therapeutics and Supportive Care Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Cancer Therapeutics and Supportive Care Drugs size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Cancer Therapeutics and Supportive Care Drugs market size is expected to grow at a CAGR of 8.6% for the next five years.
Market segmentation
Cancer Therapeutics and Supportive Care Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Cancer Therapeutics
Supportive Care Drugs
Market segment by Application, can be divided into
Hospital
Retail Pharmacies
Market segment by players, this report covers
Abbott Laboratories
AstraZeneca plc
Astellas Pharma
Bristol-Myers Squibb
Johnson & Johnson
Eli Lilly
Novartis
Pfizer
Sanofi
Teva Pharmaceuticals
Takeda Pharmaceuticals
AbbVie
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Cancer Therapeutics and Supportive Care Drugs
1.2 Classification of Cancer Therapeutics and Supportive Care Drugs by Type
1.2.1 Overview: Global Cancer Therapeutics and Supportive Care Drugs Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Cancer Therapeutics and Supportive Care Drugs Revenue Market Share by Type in 2020
1.2.3 Cancer Therapeutics
1.2.4 Supportive Care Drugs
1.3 Global Cancer Therapeutics and Supportive Care Drugs Market by Application
1.3.1 Overview: Global Cancer Therapeutics and Supportive Care Drugs Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Retail Pharmacies
1.4 Global Cancer Therapeutics and Supportive Care Drugs Market Size & Forecast
1.5 Global Cancer Therapeutics and Supportive Care Drugs Market Size and Forecast by Region
1.5.1 Global Cancer Therapeutics and Supportive Care Drugs Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Cancer Therapeutics and Supportive Care Drugs Market Size by Region, (2016-2021)
1.5.3 North America Cancer Therapeutics and Supportive Care Drugs Market Size and Prospect (2016-2026)
1.5.4 Europe Cancer Therapeutics and Supportive Care Drugs Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Cancer Therapeutics and Supportive Care Drugs Market Size and Prospect (2016-2026)
1.5.6 South America Cancer Therapeutics and Supportive Care Drugs Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Cancer Therapeutics and Supportive Care Drugs Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Cancer Therapeutics and Supportive Care Drugs Market Drivers
1.6.2 Cancer Therapeutics and Supportive Care Drugs Market Restraints
1.6.3 Cancer Therapeutics and Supportive Care Drugs Trends Analysis
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Cancer Therapeutics and Supportive Care Drugs Product and Solutions
2.1.4 Abbott Laboratories Cancer Therapeutics and Supportive Care Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 AstraZeneca plc
2.2.1 AstraZeneca plc Details
2.2.2 AstraZeneca plc Major Business
2.2.3 AstraZeneca plc Cancer Therapeutics and Supportive Care Drugs Product and Solutions
2.2.4 AstraZeneca plc Cancer Therapeutics and Supportive Care Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 AstraZeneca plc Recent Developments and Future Plans
2.3 Astellas Pharma
2.3.1 Astellas Pharma Details
2.3.2 Astellas Pharma Major Business
2.3.3 Astellas Pharma Cancer Therapeutics and Supportive Care Drugs Product and Solutions
2.3.4 Astellas Pharma Cancer Therapeutics and Supportive Care Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Astellas Pharma Recent Developments and Future Plans
2.4 Bristol-Myers Squibb
2.4.1 Bristol-Myers Squibb Details
2.4.2 Bristol-Myers Squibb Major Business
2.4.3 Bristol-Myers Squibb Cancer Therapeutics and Supportive Care Drugs Product and Solutions
2.4.4 Bristol-Myers Squibb Cancer Therapeutics and Supportive Care Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business
2.5.3 Johnson & Johnson Cancer Therapeutics and Supportive Care Drugs Product and Solutions
2.5.4 Johnson & Johnson Cancer Therapeutics and Supportive Care Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Johnson & Johnson Recent Developments and Future Plans
2.6 Eli Lilly
2.6.1 Eli Lilly Details
2.6.2 Eli Lilly Major Business
2.6.3 Eli Lilly Cancer Therapeutics and Supportive Care Drugs Product and Solutions
2.6.4 Eli Lilly Cancer Therapeutics and Supportive Care Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Eli Lilly Recent Developments and Future Plans
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis Cancer Therapeutics and Supportive Care Drugs Product and Solutions
2.7.4 Novartis Cancer Therapeutics and Supportive Care Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Novartis Recent Developments and Future Plans
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Cancer Therapeutics and Supportive Care Drugs Product and Solutions
2.8.4 Pfizer Cancer Therapeutics and Supportive Care Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Pfizer Recent Developments and Future Plans
2.9 Sanofi
2.9.1 Sanofi Details
2.9.2 Sanofi Major Business
2.9.3 Sanofi Cancer Therapeutics and Supportive Care Drugs Product and Solutions
2.9.4 Sanofi Cancer Therapeutics and Supportive Care Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Sanofi Recent Developments and Future Plans
2.10 Teva Pharmaceuticals
2.10.1 Teva Pharmaceuticals Details
2.10.2 Teva Pharmaceuticals Major Business
2.10.3 Teva Pharmaceuticals Cancer Therapeutics and Supportive Care Drugs Product and Solutions
2.10.4 Teva Pharmaceuticals Cancer Therapeutics and Supportive Care Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Teva Pharmaceuticals Recent Developments and Future Plans
2.11 Takeda Pharmaceuticals
2.11.1 Takeda Pharmaceuticals Details
2.11.2 Takeda Pharmaceuticals Major Business
2.11.3 Takeda Pharmaceuticals Cancer Therapeutics and Supportive Care Drugs Product and Solutions
2.11.4 Takeda Pharmaceuticals Cancer Therapeutics and Supportive Care Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Takeda Pharmaceuticals Recent Developments and Future Plans
2.12 AbbVie
2.12.1 AbbVie Details
2.12.2 AbbVie Major Business
2.12.3 AbbVie Cancer Therapeutics and Supportive Care Drugs Product and Solutions
2.12.4 AbbVie Cancer Therapeutics and Supportive Care Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 AbbVie Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Cancer Therapeutics and Supportive Care Drugs Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Cancer Therapeutics and Supportive Care Drugs Players Market Share
3.2.2 Top 10 Cancer Therapeutics and Supportive Care Drugs Players Market Share
3.2.3 Market Competition Trend
3.3 Cancer Therapeutics and Supportive Care Drugs Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Cancer Therapeutics and Supportive Care Drugs Revenue and Market Share by Type (2016-2021)
4.2 Global Cancer Therapeutics and Supportive Care Drugs Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Cancer Therapeutics and Supportive Care Drugs Revenue Market Share by Application (2016-2021)
5.2 Cancer Therapeutics and Supportive Care Drugs Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Cancer Therapeutics and Supportive Care Drugs Revenue by Type (2016-2026)
6.2 North America Cancer Therapeutics and Supportive Care Drugs Revenue by Application (2016-2026)
6.3 North America Cancer Therapeutics and Supportive Care Drugs Market Size by Country
6.3.1 North America Cancer Therapeutics and Supportive Care Drugs Revenue by Country (2016-2026)
6.3.2 United States Cancer Therapeutics and Supportive Care Drugs Market Size and Forecast (2016-2026)
6.3.3 Canada Cancer Therapeutics and Supportive Care Drugs Market Size and Forecast (2016-2026)
6.3.4 Mexico Cancer Therapeutics and Supportive Care Drugs Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Cancer Therapeutics and Supportive Care Drugs Revenue by Type (2016-2026)
7.2 Europe Cancer Therapeutics and Supportive Care Drugs Revenue by Application (2016-2026)
7.3 Europe Cancer Therapeutics and Supportive Care Drugs Market Size by Country
7.3.1 Europe Cancer Therapeutics and Supportive Care Drugs Revenue by Country (2016-2026)
7.3.2 Germany Cancer Therapeutics and Supportive Care Drugs Market Size and Forecast (2016-2026)
7.3.3 France Cancer Therapeutics and Supportive Care Drugs Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Cancer Therapeutics and Supportive Care Drugs Market Size and Forecast (2016-2026)
7.3.5 Russia Cancer Therapeutics and Supportive Care Drugs Market Size and Forecast (2016-2026)
7.3.6 Italy Cancer Therapeutics and Supportive Care Drugs Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Cancer Therapeutics and Supportive Care Drugs Revenue by Type (2016-2026)
8.2 Asia-Pacific Cancer Therapeutics and Supportive Care Drugs Revenue by Application (2016-2026)
8.3 Asia-Pacific Cancer Therapeutics and Supportive Care Drugs Market Size by Region
8.3.1 Asia-Pacific Cancer Therapeutics and Supportive Care Drugs Revenue by Region (2016-2026)
8.3.2 China Cancer Therapeutics and Supportive Care Drugs Market Size and Forecast (2016-2026)
8.3.3 Japan Cancer Therapeutics and Supportive Care Drugs Market Size and Forecast (2016-2026)
8.3.4 South Korea Cancer Therapeutics and Supportive Care Drugs Market Size and Forecast (2016-2026)
8.3.5 India Cancer Therapeutics and Supportive Care Drugs Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Cancer Therapeutics and Supportive Care Drugs Market Size and Forecast (2016-2026)
8.3.7 Australia Cancer Therapeutics and Supportive Care Drugs Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Cancer Therapeutics and Supportive Care Drugs Revenue by Type (2016-2026)
9.2 South America Cancer Therapeutics and Supportive Care Drugs Revenue by Application (2016-2026)
9.3 South America Cancer Therapeutics and Supportive Care Drugs Market Size by Country
9.3.1 South America Cancer Therapeutics and Supportive Care Drugs Revenue by Country (2016-2026)
9.3.2 Brazil Cancer Therapeutics and Supportive Care Drugs Market Size and Forecast (2016-2026)
9.3.3 Argentina Cancer Therapeutics and Supportive Care Drugs Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Cancer Therapeutics and Supportive Care Drugs Revenue by Type (2016-2026)
10.2 Middle East & Africa Cancer Therapeutics and Supportive Care Drugs Revenue by Application (2016-2026)
10.3 Middle East & Africa Cancer Therapeutics and Supportive Care Drugs Market Size by Country
10.3.1 Middle East & Africa Cancer Therapeutics and Supportive Care Drugs Revenue by Country (2016-2026)
10.3.2 Turkey Cancer Therapeutics and Supportive Care Drugs Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Cancer Therapeutics and Supportive Care Drugs Market Size and Forecast (2016-2026)
10.3.4 UAE Cancer Therapeutics and Supportive Care Drugs Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Cancer Therapeutics and Supportive Care Drugs Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Cancer Therapeutics and Supportive Care Drugs Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Cancer Therapeutics and Supportive Care Drugs Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Cancer Therapeutics and Supportive Care Drugs Revenue (USD Million) by Region (2016-2021)
Table 5. Global Cancer Therapeutics and Supportive Care Drugs Revenue Market Share by Region (2021-2026)
Table 6. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Laboratories Major Business
Table 8. Abbott Laboratories Cancer Therapeutics and Supportive Care Drugs Product and Solutions
Table 9. Abbott Laboratories Cancer Therapeutics and Supportive Care Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. AstraZeneca plc Corporate Information, Head Office, and Major Competitors
Table 11. AstraZeneca plc Major Business
Table 12. AstraZeneca plc Cancer Therapeutics and Supportive Care Drugs Product and Solutions
Table 13. AstraZeneca plc Cancer Therapeutics and Supportive Care Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Astellas Pharma Corporate Information, Head Office, and Major Competitors
Table 15. Astellas Pharma Major Business
Table 16. Astellas Pharma Cancer Therapeutics and Supportive Care Drugs Product and Solutions
Table 17. Astellas Pharma Cancer Therapeutics and Supportive Care Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors
Table 19. Bristol-Myers Squibb Major Business
Table 20. Bristol-Myers Squibb Cancer Therapeutics and Supportive Care Drugs Product and Solutions
Table 21. Bristol-Myers Squibb Cancer Therapeutics and Supportive Care Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 23. Johnson & Johnson Major Business
Table 24. Johnson & Johnson Cancer Therapeutics and Supportive Care Drugs Product and Solutions
Table 25. Johnson & Johnson Cancer Therapeutics and Supportive Care Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Eli Lilly Corporate Information, Head Office, and Major Competitors
Table 27. Eli Lilly Major Business
Table 28. Eli Lilly Cancer Therapeutics and Supportive Care Drugs Product and Solutions
Table 29. Eli Lilly Cancer Therapeutics and Supportive Care Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Novartis Corporate Information, Head Office, and Major Competitors
Table 31. Novartis Major Business
Table 32. Novartis Cancer Therapeutics and Supportive Care Drugs Product and Solutions
Table 33. Novartis Cancer Therapeutics and Supportive Care Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Pfizer Corporate Information, Head Office, and Major Competitors
Table 35. Pfizer Major Business
Table 36. Pfizer Cancer Therapeutics and Supportive Care Drugs Product and Solutions
Table 37. Pfizer Cancer Therapeutics and Supportive Care Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Sanofi Corporate Information, Head Office, and Major Competitors
Table 39. Sanofi Major Business
Table 40. Sanofi Cancer Therapeutics and Supportive Care Drugs Product and Solutions
Table 41. Sanofi Cancer Therapeutics and Supportive Care Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Teva Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 43. Teva Pharmaceuticals Major Business
Table 44. Teva Pharmaceuticals Cancer Therapeutics and Supportive Care Drugs Product and Solutions
Table 45. Teva Pharmaceuticals Cancer Therapeutics and Supportive Care Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Takeda Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 47. Takeda Pharmaceuticals Major Business
Table 48. Takeda Pharmaceuticals Cancer Therapeutics and Supportive Care Drugs Product and Solutions
Table 49. Takeda Pharmaceuticals Cancer Therapeutics and Supportive Care Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. AbbVie Corporate Information, Head Office, and Major Competitors
Table 51. AbbVie Major Business
Table 52. AbbVie Cancer Therapeutics and Supportive Care Drugs Product and Solutions
Table 53. AbbVie Cancer Therapeutics and Supportive Care Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Global Cancer Therapeutics and Supportive Care Drugs Revenue (USD Million) by Players (2019-2021)
Table 55. Global Cancer Therapeutics and Supportive Care Drugs Revenue Share by Players (2019-2021)
Table 56. Breakdown of Cancer Therapeutics and Supportive Care Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 57. Cancer Therapeutics and Supportive Care Drugs Players Head Office, Products and Services Provided
Table 58. Cancer Therapeutics and Supportive Care Drugs Mergers & Acquisitions in the Past Five Years
Table 59. Cancer Therapeutics and Supportive Care Drugs New Entrants and Expansion Plans
Table 60. Global Cancer Therapeutics and Supportive Care Drugs Revenue (USD Million) by Type (2016-2021)
Table 61. Global Cancer Therapeutics and Supportive Care Drugs Revenue Share by Type (2016-2021)
Table 62. Global Cancer Therapeutics and Supportive Care Drugs Revenue Forecast by Type (2021-2026)
Table 63. Global Cancer Therapeutics and Supportive Care Drugs Revenue by Application (2016-2021)
Table 64. Global Cancer Therapeutics and Supportive Care Drugs Revenue Forecast by Application (2021-2026)
Table 65. North America Cancer Therapeutics and Supportive Care Drugs Revenue by Type (2016-2021) & (USD Million)
Table 66. North America Cancer Therapeutics and Supportive Care Drugs Revenue by Type (2021-2026) & (USD Million)
Table 67. North America Cancer Therapeutics and Supportive Care Drugs Revenue by Application (2016-2021) & (USD Million)
Table 68. North America Cancer Therapeutics and Supportive Care Drugs Revenue by Application (2021-2026) & (USD Million)
Table 69. North America Cancer Therapeutics and Supportive Care Drugs Revenue by Country (2016-2021) & (USD Million)
Table 70. North America Cancer Therapeutics and Supportive Care Drugs Revenue by Country (2021-2026) & (USD Million)
Table 71. Europe Cancer Therapeutics and Supportive Care Drugs Revenue by Type (2016-2021) & (USD Million)
Table 72. Europe Cancer Therapeutics and Supportive Care Drugs Revenue by Type (2021-2026) & (USD Million)
Table 73. Europe Cancer Therapeutics and Supportive Care Drugs Revenue by Application (2016-2021) & (USD Million)
Table 74. Europe Cancer Therapeutics and Supportive Care Drugs Revenue by Application (2021-2026) & (USD Million)
Table 75. Europe Cancer Therapeutics and Supportive Care Drugs Revenue by Country (2016-2021) & (USD Million)
Table 76. Europe Cancer Therapeutics and Supportive Care Drugs Revenue by Country (2021-2026) & (USD Million)
Table 77. Asia-Pacific Cancer Therapeutics and Supportive Care Drugs Revenue by Type (2016-2021) & (USD Million)
Table 78. Asia-Pacific Cancer Therapeutics and Supportive Care Drugs Revenue by Type (2021-2026) & (USD Million)
Table 79. Asia-Pacific Cancer Therapeutics and Supportive Care Drugs Revenue by Application (2016-2021) & (USD Million)
Table 80. Asia-Pacific Cancer Therapeutics and Supportive Care Drugs Revenue by Application (2021-2026) & (USD Million)
Table 81. Asia-Pacific Cancer Therapeutics and Supportive Care Drugs Revenue by Region (2016-2021) & (USD Million)
Table 82. Asia-Pacific Cancer Therapeutics and Supportive Care Drugs Revenue by Region (2021-2026) & (USD Million)
Table 83. South America Cancer Therapeutics and Supportive Care Drugs Revenue by Type (2016-2021) & (USD Million)
Table 84. South America Cancer Therapeutics and Supportive Care Drugs Revenue by Type (2021-2026) & (USD Million)
Table 85. South America Cancer Therapeutics and Supportive Care Drugs Revenue by Application (2016-2021) & (USD Million)
Table 86. South America Cancer Therapeutics and Supportive Care Drugs Revenue by Application (2021-2026) & (USD Million)
Table 87. South America Cancer Therapeutics and Supportive Care Drugs Revenue by Country (2016-2021) & (USD Million)
Table 88. South America Cancer Therapeutics and Supportive Care Drugs Revenue by Country (2021-2026) & (USD Million)
Table 89. Middle East & Africa Cancer Therapeutics and Supportive Care Drugs Revenue by Type (2016-2021) & (USD Million)
Table 90. Middle East & Africa Cancer Therapeutics and Supportive Care Drugs Revenue by Type (2021-2026) & (USD Million)
Table 91. Middle East & Africa Cancer Therapeutics and Supportive Care Drugs Revenue by Application (2016-2021) & (USD Million)
Table 92. Middle East & Africa Cancer Therapeutics and Supportive Care Drugs Revenue by Application (2021-2026) & (USD Million)
Table 93. Middle East & Africa Cancer Therapeutics and Supportive Care Drugs Revenue by Country (2016-2021) & (USD Million)
Table 94. Middle East & Africa Cancer Therapeutics and Supportive Care Drugs Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Cancer Therapeutics and Supportive Care Drugs Picture
Figure 2. Global Cancer Therapeutics and Supportive Care Drugs Revenue Market Share by Type in 2020
Figure 3. Cancer Therapeutics
Figure 4. Supportive Care Drugs
Figure 5. Cancer Therapeutics and Supportive Care Drugs Revenue Market Share by Application in 2020
Figure 6. Hospital Picture
Figure 7. Retail Pharmacies Picture
Figure 8. Global Cancer Therapeutics and Supportive Care Drugs Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 9. Global Cancer Therapeutics and Supportive Care Drugs Revenue and Forecast (2016-2026) & (USD Million)
Figure 10. Global Cancer Therapeutics and Supportive Care Drugs Revenue Market Share by Region (2016-2026)
Figure 11. Global Cancer Therapeutics and Supportive Care Drugs Revenue Market Share by Region in 2020
Figure 12. North America Cancer Therapeutics and Supportive Care Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 13. Europe Cancer Therapeutics and Supportive Care Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Asia-Pacific Cancer Therapeutics and Supportive Care Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. South America Cancer Therapeutics and Supportive Care Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Cancer Therapeutics and Supportive Care Drugs Market Drivers
Figure 17. Cancer Therapeutics and Supportive Care Drugs Market Restraints
Figure 18. Cancer Therapeutics and Supportive Care Drugs Market Trends
Figure 19. Abbott Laboratories Recent Developments and Future Plans
Figure 20. AstraZeneca plc Recent Developments and Future Plans
Figure 21. Astellas Pharma Recent Developments and Future Plans
Figure 22. Bristol-Myers Squibb Recent Developments and Future Plans
Figure 23. Johnson & Johnson Recent Developments and Future Plans
Figure 24. Eli Lilly Recent Developments and Future Plans
Figure 25. Novartis Recent Developments and Future Plans
Figure 26. Pfizer Recent Developments and Future Plans
Figure 27. Sanofi Recent Developments and Future Plans
Figure 28. Teva Pharmaceuticals Recent Developments and Future Plans
Figure 29. Takeda Pharmaceuticals Recent Developments and Future Plans
Figure 30. AbbVie Recent Developments and Future Plans
Figure 32. Global Cancer Therapeutics and Supportive Care Drugs Revenue Share by Players in 2020
Figure 33. Cancer Therapeutics and Supportive Care Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 34. Global Top 3 Players Cancer Therapeutics and Supportive Care Drugs Revenue Market Share in 2020
Figure 35. Global Top 10 Players Cancer Therapeutics and Supportive Care Drugs Revenue Market Share in 2020
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 37. Global Cancer Therapeutics and Supportive Care Drugs Revenue Share by Type in 2020
Figure 38. Global Cancer Therapeutics and Supportive Care Drugs Market Share Forecast by Type (2021-2026)
Figure 39. Global Cancer Therapeutics and Supportive Care Drugs Revenue Share by Application in 2020
Figure 40. Global Cancer Therapeutics and Supportive Care Drugs Market Share Forecast by Application (2021-2026)
Figure 41. North America Cancer Therapeutics and Supportive Care Drugs Sales Market Share by Type (2016-2026)
Figure 42. North America Cancer Therapeutics and Supportive Care Drugs Sales Market Share by Application (2016-2026)
Figure 43. North America Cancer Therapeutics and Supportive Care Drugs Revenue Market Share by Country (2016-2026)
Figure 44. United States Cancer Therapeutics and Supportive Care Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Cancer Therapeutics and Supportive Care Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Cancer Therapeutics and Supportive Care Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Cancer Therapeutics and Supportive Care Drugs Sales Market Share by Type (2016-2026)
Figure 48. Europe Cancer Therapeutics and Supportive Care Drugs Sales Market Share by Application (2016-2026)
Figure 49. Europe Cancer Therapeutics and Supportive Care Drugs Revenue Market Share by Country (2016-2026)
Figure 50. Germany Cancer Therapeutics and Supportive Care Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Cancer Therapeutics and Supportive Care Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Cancer Therapeutics and Supportive Care Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Cancer Therapeutics and Supportive Care Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Cancer Therapeutics and Supportive Care Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Cancer Therapeutics and Supportive Care Drugs Sales Market Share by Type (2016-2026)
Figure 56. Asia-Pacific Cancer Therapeutics and Supportive Care Drugs Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Cancer Therapeutics and Supportive Care Drugs Revenue Market Share by Region (2016-2026)
Figure 58. China Cancer Therapeutics and Supportive Care Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Cancer Therapeutics and Supportive Care Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South Korea Cancer Therapeutics and Supportive Care Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Cancer Therapeutics and Supportive Care Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Cancer Therapeutics and Supportive Care Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Cancer Therapeutics and Supportive Care Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Cancer Therapeutics and Supportive Care Drugs Sales Market Share by Type (2016-2026)
Figure 65. South America Cancer Therapeutics and Supportive Care Drugs Sales Market Share by Application (2016-2026)
Figure 66. South America Cancer Therapeutics and Supportive Care Drugs Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Cancer Therapeutics and Supportive Care Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Cancer Therapeutics and Supportive Care Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East and Africa Cancer Therapeutics and Supportive Care Drugs Sales Market Share by Type (2016-2026)
Figure 70. Middle East and Africa Cancer Therapeutics and Supportive Care Drugs Sales Market Share by Application (2016-2026)
Figure 71. Middle East and Africa Cancer Therapeutics and Supportive Care Drugs Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Cancer Therapeutics and Supportive Care Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Cancer Therapeutics and Supportive Care Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. UAE Cancer Therapeutics and Supportive Care Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source
世界の頭頸部がん治療薬/治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Head and Neck Cancer Drugs/Therapeutics Market The global Head and Neck Cancer Drugs/Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis…- 世界の腎臓がん治療薬市場規模・現状・予測（2021年-2027年） Kidney Cancer Treatment Drugs are drugs used to cure kidney cancer. Market growth is largely driven by factors such as availability of novel drugs, presence of strong pipeline, and rise in incidence of renal cancer due to growing geriatric population and more prominent smoking habits. Market Analysi…
- 世界の腎臓がん治療薬市場規模・現状・予測（2021年-2027年） Kidney Cancer Treatment Drugs are drugs used to cure kidney cancer. Market growth is largely driven by factors such as availability of novel drugs, presence of strong pipeline, and rise in incidence of renal cancer due to growing geriatric population and more prominent smoking habits. Market Analysi…
- 世界の肛門がん治療薬市場規模・現状・予測（2021年-2027年） A cancer can be defined when the normal cells lose their ability to control, their growth or multiplication and thus invade the tissues and spread to the body parts. Anal cancer is often called as squamous cell carcinoma which arises from the cells around or in the anal opening or in rare cases it m…
- 世界の尿路上皮がん治療薬市場 2021：企業別、地域別、種類・用途別 The Urothelial Cancer Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…